dear future client letter_may 2016
TRANSCRIPT
June 30, 2016Dear Future Client:
This letter is to inform you that INPERNUM PHARMA SOLUTIONS is now operational and ready to work with you! Inpernum provides pharmaceutical development consulting and delivers team-oriented solutions to your complex drug development challenges. Inpernum functions to resolve barriers imposed by regulatory authorities, formulate clinical study designs and/or development plans and address the full range of obstructions that occur throughout the drug development process.
Our business model offers clients flexibility, allowing clients to work directly with a senior level drug development consultant team. Our team of consultants, who have extensive expertise within large pharma, biotech, contract research organizations, clinical practice, and the Food and Drug Administration, are eager to partner with you to aid in driving the development of your assets from pre-IND through NDA submission.
What makes Inpernum different from every other consulting firms is that we strive to go beyond a purely transactional service by implementing a means to build trust and form a long term relationship with clients. To this end, Inpernum offers amenable pricing models to meet the distinct needs of each opportunity and client. Inpernum works with clients to offer a broad range of drug development services including, but not limited to global regulatory strategy consulting, gap analyses/due diligence, risk mitigation strategies, clinical trial feasibility, indication optimization, and integrated drug development plan s.
Recent trends have indicated that many companies are hesitant to hire costly C-level positions during the earliest stages of biotech company growth. Inpernum Pharma Solutions can provide you with the aforementioned expertise in a cost effective manner and work to limit your potential voids in decision making or hesitations in execution. Inpernum will be a fully vested development partner to help you achieve your next development milestone or business goal.
Please contact me at your earliest convenience to discuss your company’s immediate needs.
Kind regards,
Steven A. CastilloChief Executive Officer